Clorazepate Dipotassium Tablet
Product Images NDC 60505-4754

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Clorazepate Dipotassium (NDC 60505-4754). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

15mg1000s (15mg1000s)

This is a description for a medicine called Clorazepate Dipotassium Tablets, USP. The prescription recommended is 5t cotans 15 g ofcorsats dpoasshm, P oqaant o 11.5mg on the soreatar0- 257 e 7. The medication comes in a bottle with 1000 tablets. Patients are advised to follow the Medication Guide provided separately. The manufacturer is Apotex Corp, located in Conerama, LG, Z15Woag AT, Mogssar, USA.*

FDA Label Image

15mg100s (15mg100s)

This is a description of Clorazepate Dipotassium tablets. Each tablet contains 15mg of Clorazepate Dipotassium, equivalent to 11.5mg of Clorazepate. The medication is stored in a tightly closed container at a temperature between 20°C - 25°C. It is important to keep the medication away from moisture and protect it from light. Each bottle contains 100 tablets and comes with a Medication Guide for the patient. The medication is manufactured by CorePharma for Apotex Corp, located in Weston, Florida. The expiration date and serial number are not available.*

FDA Label Image

15mg30s (15mg30s)

FDA Label Image

15mg500s (15mg500s)

Each tablet has 15mg of clorazepate dipotassium, which is equal to 1.5mg of clorazepate. The package has 500 tablets, and the storage temperature is between 20°C-25°C (68°F - 77°F), with protection from moisture. It is a USP tight, light-resistant container, and should not be accepted if the seal is broken or missing. See the prescribing information for details. The pharmacist should include the Medication Guide provided separately in the package for each patient. The manufacturer is CorePharma, LLC, based in Middlesex, NJ, and manufactured for Apotex Corp, in Weston, Florida, USA.*

FDA Label Image

3.75mg1000s (3.75mg1000s)

Clorazepate Dipotassium Tablets of 375mg quantity available for dispensing by APOTEX CORP. The package contains medication guide which is provided separately to each patient. Other details including manufacturing and storage temperature are mentioned on the package.*

FDA Label Image

3.75mg100s (3.75mg100s)

FDA Label Image

3.75mg30s (3.75mg30s)

This text contains some information related to medication and prescription. It seems to include a dosage of "Clorazepate Dipotassium" tablets, which are available as 3.75mg. The text also includes some contact details related to the manufacturer or distributor named "APoTEX CORP". However, other parts of the text like "eohusicmarss", "Coruegen", "Qe 20 maot" are not interpretable. Overall, the description is not very useful and looks like a random combination of characters and letters.*

FDA Label Image

3.75mg500s (3.75mg500s)

FDA Label Image

7.5mg1000s (7.5mg1000s)

This is a description of Clorazepate Dipotassium tablets of 7.5mg strength. The text includes information about dosage, manufacturer, and storage instructions. The medication guide is provided separately to each patient, and the pharmacist could dispense it. The tablets are produced by Apotex Corporation in a place called Watson, and the address is provided. The text also contains some unclear characters and broken letters.*

FDA Label Image

7.5mg100s (7.5mg100s)

FDA Label Image

7.5mg30s (7.5mg30s)

FDA Label Image

7.5mg500s (7.5mg500s)

This appears to be a label or packaging information for Clorazepate Dipotassium Tablets, USP, manufactured by ApoTEX CORP. The label mentions the strength of the tablets (50mg), storage temperature (controlled at room temperature), and possibly some safety information (sposien 0%). The rest of the text is not legible due to errors.*

FDA Label Image

Structure (Clorazepatedipotassium)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.